Study 4: Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Pediatric Subjects with Tourette Syndrome
Ages: 6-17
Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ
Contact: Caroline Sabatino, 908-522-5901
For more information, please visit the following link: http://www.prnewswire.com/news-releases/neurocrine-announces-initiation-of-phase-ii-clinical-study-of-vmat2-inhibitor-valbenazine-in-children-and-adolescents-with-tourette-syndrome-300213365.html
Overlook Medical Center has additional Tourette Syndrome studies available
Study 1: Multimodal Dietary Treatment in Tourette’s Syndrome
Ages: 12-17
Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ
Contact: Caroline Sabatino, 908-522-5901
Patients with TS age 12-17 are eligible to participate. We are testing a group of dietary supplements that act to increase inhibitory chemical signals in the brain, detoxify environmental toxins, strengthen the body’s metabolism, and support brain nerve cell membranes. Subjects will also follow a Whole Food diet. The study lasts for 8 weeks and involves 3 visits to our office.
Study 2: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects with Tourette Syndrome
Ages: 18-64
Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ
Contact: Caroline Sabatino, 908-522-5901
For more information, please visit the following link: https://clinicaltrials.gov/ct2/show/NCT02581865
Study 3: Ecopipam Treatment of Tourette’s Syndrome in Subjects 7-17 Years
Ages: 7-17
Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ
Contact: Caroline Sabatino, 908-522-5901
For more information, please visit the following link: https://clinicaltrials.gov/ct2/show/NCT02102698?term=Ecopipam+treatment+of+Tourette%E2%80%99s+Syndrome+in+Subjects+7-17+Years&rank=1
